HTRS | Pfizer Visiting Professorship Program
Shared Decision Making in Hemophilia
Overview
The HTRS | Pfizer Visiting Professorship Program brings expert-led, customized education directly to institutions to address gaps in hemophilia care.
Selected institutions are paired with a Visiting Professor (or up to two, if appropriate) to deliver a tailored educational program focused on shared decision making (SDM), multidisciplinary care, and evolving treatment strategies. Programs are designed around each site’s unique needs to ensure meaningful, practical impact on clinical practice.
Application Deadline: June 18, 2026 at 5:00 PM ET
Program Highlights
- Customized, site-specific education (up to 2 days)
- Focus on shared decision making and emerging therapies
- Multidisciplinary engagement across care teams
- Opportunity to host up to two Visiting Professors per program
- Designed to create lasting improvements in patient care and provider knowledge
Funding & Program Structure
This flexible funding mechanism providing up to $6,000 per meeting can support a wide range of educational activities.
Whether you are planning a single-session event or a multi-day program, this initiative is designed to bring leading expertise directly to your institution.
HTRS will select one Visiting Professor(s) based on the recipient’s approved program and knowledge gaps. Travel expenses and honoraria for the Visiting Professor(s) will be covered separately and should not be a part of your grant application budget.
Example Educational Formats
Funding may be used to support programs such as:
For hematologists, advanced practice providers, nurses, social workers, physical therapists, and other HTC staff
Featuring in-depth presentations on SDM strategies and novel therapies
Bringing together providers and staff for updates on patient-centered care and evolving treatment landscapes
Focused on advancing shared decision making among physicians, trainees, and allied healthcare professionals
Including hands-on workshops or expert-led seminars for early-career practitioners
Incorporating patient and caregiver engagement to strengthen shared treatment planning
Designed in partnership with advocacy organizations to deliver education for patients, caregivers, and community leaders—focused on shared decision making, treatment awareness, and empowering individuals to actively participate in care decisions
Supporting alignment of clinical practice with current evidence and patient-centered care models
Available Resources
Request for Proposal: Click Here
Online Application Template: Click Here
Application Portal: Click Here
Application Deadline: June 18, 2026 at 5:00 PM ET
Apply
Applications must be submitted through Pfizer’s online grant portal.
Bring expert hemophilia education to your institution and strengthen patient-centered care through shared decision making.
Application Deadline: June 18, 2026 at 5:00 PM ET
2025 Program Examples
To support future applicants, below are examples of previously selected program topics and formats from the 2025 grant cycle:
Shared Decision Making & Emerging Therapies in Pediatric to Adult Transition
This program focused on improving transitions of care through shared decision making, with education on patient engagement strategies and emerging therapies including gene therapy, rebalancing agents, and bispecific antibodies. Participants called to develop practical tools to support transition workflows across multidisciplinary teams.
Training on Culturally Competent Shared Decision Making
This program addressed key barriers related to health literacy, cultural competency, and patient engagement. Sessions included motivational interviewing, communication strategies, and approaches to empower patients to actively participate in treatment decisions.
Women/Females with Bleeding Disorders + Musculoskeletal Ultrasound Training
A dual-focus program, requesting two visiting professors, designed to improve recognition and management of bleeding disorders in women and adolescent females, alongside hands-on training in musculoskeletal ultrasound. The program combined multidisciplinary education, case-based learning, and clinical application to support earlier diagnosis and improved patient outcomes.
Questions
Contact: [email protected]